Company Profile
Price and Volume
Recent Price 1.39
52 Week High 2.46
52 Week Low 1.00
Avg. Daily Vol. (Mil) 0.06
Beta (3 year) 1.03
Share Related Items
Mkt Cap (Mil) 57.24
Shares Out (Mil) 41.18
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.50
Current Ratio 4.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 5.56
Price/Cash Flow -3.70
Per Share Data
Earnings -0.40
Sales 0.00
Book Value 0.25
Cash Flow -0.38
Business Summary
A development stage Company, which focuses on research and development efforts on the development of REOLYSIN (r) , its potential cancer therapeutic.
General Information
1167 Kensington Crescent NW
Suite 210
Calgary, Alberta, T2N 1X7
www.oncolyticsbiotech.com
Industry : Drugs
Sector: Health Care
Employees: 9
CEO: Dr. Bradley G. Thompson,
Short Interest
Current Month (Mil) 0.00
Previous Month (Mil) 0.00
Short Interest Ratio (Days) 0.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -128.90
Return on Investments -162.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Free Newsletters from TheStreet

Cramer's Daily Booyah!
Highlights of Jim Cramer's videos
on TheStreet.com TV & his
"Mad Money" TV show.
Before the Bell
All the information you
need to position yourself
for the day ahead.
Submit
We respect your privacy.

Premium Stock Ideas